These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8081076)

  • 1. Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma.
    Cazzola M; Matera MG; Liccardi G; Sacerdoti G; D'Amato G; Rossi F
    Pulm Pharmacol; 1994 Apr; 7(2):91-7. PubMed ID: 8081076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The muscarinic M1-receptor-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients.
    Ukena D; Wehinger C; Engelstätter R; Steinijans V; Sybrecht GW
    Eur Respir J; 1993 Mar; 6(3):378-82. PubMed ID: 8472828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An M1-selective muscarinic receptor antagonist telenzepine improves lung function in patients with chronic obstructive bronchitis.
    Cazzola M; D'Amato G; Guidetti E; Staudinger H; Steinijans VW; Kilian U
    Pulm Pharmacol; 1990; 3(4):185-9. PubMed ID: 2135223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single evening administration of a new antimuscarinic agent telenzepine in therapy of acute duodenal ulcer. Results of a randomized double-blind comparative study versus pirenzepine].
    Dammann HG; Dreyer M; Wolf N; Müller P; Merk-Härtelt B; Simon B
    Z Gastroenterol; 1989 Apr; 27(4):203-6. PubMed ID: 2658396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
    Simon B; Reinicke HG; Dammann HG; Müller P
    Z Gastroenterol; 1990 Feb; 28(2):90-3. PubMed ID: 2181788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the M1-selective telenzepine on esophageal acid exposure in healthy volunteers.
    Stockbrügger RW; Armbrecht U; Reul W
    Z Gastroenterol; 1988 Jun; 26(6):297-302. PubMed ID: 3061181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia.
    Galvan M; Boer R; Schudt C
    Eur J Pharmacol; 1989 Aug; 167(1):1-10. PubMed ID: 2776837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present status and future perspectives of muscarinic receptor antagonists.
    Londong W
    Scand J Gastroenterol Suppl; 1986; 125():55-60. PubMed ID: 2881347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exocrine pancreatic secretion in man following one week of M1-muscarinic receptor blockade.
    Malfertheiner P; Nelson DK; Kemmer TP; Glasbrenner B; Schneider A; Ditschuneit H
    Aliment Pharmacol Ther; 1993 Aug; 7(4):423-8. PubMed ID: 8218757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
    Coruzzi G; Adami M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of the muscarinic antagonist telenzepine in myenteric ganglia of the guinea-pig small intestine.
    Christofi FL; Palmer JM; Wood JD
    Eur J Pharmacol; 1991 Apr; 195(3):333-9. PubMed ID: 1868879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
    Holtmann G; Küppers U; Singer MV
    Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and tolerability of telenzepine in patients with compensated liver cirrhosis].
    Reinicke A; Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1990 Nov; 40(11):1239-41. PubMed ID: 2085337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors.
    Poli E; Monica B; Zappia L; Pozzoli C; Bertaccini G
    Gen Pharmacol; 1992 Jul; 23(4):659-64. PubMed ID: 1397972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
    Singer MV; Teyssen S; Küppers U
    Digestion; 1991; 48(1):34-42. PubMed ID: 1868967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the prolonged occupancy of M1 receptors by telenzepine protect them against the action of vagally released acetylcholine?
    Schudt C; Auriga C; Birdsall NJ; Boer R
    Pharmacology; 1988; 37 Suppl 1():32-9. PubMed ID: 3237765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Teyssen S; Niebergall-Roth E; Rausch A; Beglinger C; Riepl RL; Chari S; Singer MV
    Pancreas; 1996 Nov; 13(4):407-16. PubMed ID: 8899802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose finding study of telenzepine (1.5 vs. 3 vs 5 mg once daily) in acute treatment of duodenal ulcer. A double-blind, randomized, multicenter parallel group comparison].
    Hüttemann W; Schneider A
    Med Klin (Munich); 1989 Dec; 84(12):574-7. PubMed ID: 2695806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
    Eltze M
    Eur J Pharmacol; 1990 May; 180(1):161-8. PubMed ID: 2365000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.